市場調查報告書

大腸癌的全球市場:各模式、終端用戶、地區分析及預測(∼2027年)

Colorectal Cancer Market to 2027 - Global Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Geography

出版商 The Insight Partners 商品編碼 918663
出版日期 內容資訊 英文 229 Pages
訂單完成後即時交付
價格
大腸癌的全球市場:各模式、終端用戶、地區分析及預測(∼2027年) Colorectal Cancer Market to 2027 - Global Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Geography
出版日期: 2019年11月18日內容資訊: 英文 229 Pages
簡介

全球大腸癌市場在2018年估算達到163億3,990萬美元的規模,在2019年∼2027年的預測期間內,預計將以4.0%的年複合成長率成長,至2027年預計將達到229億5,380萬美元的規模。

本報告提供全球大腸癌市場的相關調查,市場機會和趨勢,成長及阻礙因素,各市場區隔的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • 報告概要
  • 市場區隔

第2章 要點

第3章 調查方法

  • 範圍
  • 二次調查
  • 一次研究

第4章 市場展望

  • 概要
  • PEST分析
  • 專家的意見
  • 基層護理醫生、診療的特徵(美國)
  • 各病期患者數(美國)
  • CEA檢驗數(美國)
  • 美國的大腸癌的罹患率-2018年

第5章 主要市場動態

  • 主要的市場成長要素
  • 主要的市場阻礙因素
  • 主要的市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 全球大腸癌市場收益預測與分析
  • 全球大腸癌市場,各地區:預測與分析
  • 主要企業的定位

第7章 各種模式市場分析

  • 概要
  • 各種模式市場,2018年及2027年(%)
  • 診斷類型市場
  • 治療類型市場
  • 影像診斷類型市場

第8章 各終端用戶市場分析

  • 概要
  • 各終端用戶市場,2018年及2027年(%)
  • 醫院市場
  • 診斷及研究所市場

第9章 各地區市場分析

  • 北美市場收益和至2027年的預測
  • 歐洲市場收益和至2027年的預測
  • 亞太地區市場收益和至2027年的預測
  • 中東、非洲地區市場收益和至2027年的預測
  • 中南美市場收益和至2027年的預測

第10章 大腸癌的市場產業的風景

  • 概要
  • 大腸癌市場成長策略,2016年∼2019年
  • 有機的發展
  • 無機的發展

第11章 主要企業的簡介

  • Epigenomics AG
  • Novigenix SA
  • Clinical Genomics Technologies Pty Ltd.
  • EDP Biotech Corporation
  • Volitionrx Limited
  • Abbott Laboratories
  • Amgen Inc.
  • F.Hoffmann-La Roche AG
  • Bruker Corporation
  • Quest Diagnostics Incorporated
  • Natera, Inc.
  • Guardant Health,Inc.

第12章 附錄

  • 關於The Insight Partners
  • 詞彙表
目錄
Product Code: TIPRE00006881

The global colorectal cancer market is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027.

Driving factors of the colorectal cancer are increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.

Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Generic drugs are important in oncology due to the fact that some of the anticancer drugs are only offered as generics. Patients are likely seen to abandon branded prescriptions which are majorly associated with their higher co-pays. Among developing countries such as India, where the paying capacity is relatively low, generic drugs for cancer treatment acts as a boon for both the manufacturers as well as patients due to its affordability and efficacy. For instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer under the brand name "Cizumab". One of the most striking benefit of using generic drugs is the cost that is up to 85% less than that of the branded drugs.

The global colorectal cancer market, based on the modality, is segmented into diagnosis type, therapy type, and imaging type. In 2018, the diagnosis type segment held the largest market share of the colorectal cancer market. Based on the end user, market is segmented into hospitals, diagnostic and research laboratories. Hospitals segment is expected to dominate the end user segment during the forecast period.

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, National Colorectal Cancer Roundtable and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the colorectal cancer market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Colorectal Cancer Market - By Modality
    • 1.3.2 Global Colorectal Cancer Market - By End User
    • 1.3.3 Global Colorectal Cancer Market - By Geography

2. Colorectal Cancer Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Colorectal Cancer- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Colorectal Cancer Market - North America PEST Analysis
    • 4.2.2 Colorectal Cancer Market - Europe PEST Analysis
    • 4.2.3 Colorectal Cancer Market - Asia Pacific PEST Analysis
    • 4.2.4 Colorectal Cancer Market - Middle East & Africa PEST Analysis
    • 4.2.5 Colorectal Cancer Market - South And Central America PEST Analysis
  • 4.3 Expert Opinion
  • 4.4 Primary Care Physician And Practice Characteristics (US)
    • 4.4.1 Practice Environment And Practice Patterns
    • 4.4.2 US Census Region (Prevalence- 2018)
    • 4.4.3 Typical Number Of Patients Per Week
    • 4.4.4 CRC Screening Tests Ordered, Referred Or Performed Per Month
    • 4.4.5 Number Of CRC Screening Modalities Recommended
  • 4.5 Number Of Patients By Stage (US)
  • 4.6 Number Of CEA Tests (US)
  • 4.7 US Colorectal Cancer Prevalence- 2018

5. Colorectal Cancer- Key Dynamics

  • 5.1 Key Drivers
    • 5.1.1 Increasing Prevalence Of Colorectal Cancer
    • 5.1.2 New Product Launches
    • 5.1.3 Benefits Offered By Generic Drugs
  • 5.2 Key Restraints
    • 5.2.1 Pricing Pressure On Drug Manufacturers
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Pharmaceutical Industry In Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Inclination Towards Personalized Medicine
  • 5.5 Impact Analysis

6. Colorectal Cancer Market - Global Analysis

  • 6.1 Global Colorectal Cancer Market Revenue Forecasts And Analysis
  • 6.2 Global Colorectal Cancer Market, By Geography - Forecasts And Analysis
  • 6.3 Positioning Of Key Players

7. Colorectal Cancer Market Analysis And Forecasts To 2027 - Modality

  • 7.1 Overview
  • 7.2 Global Colorectal Cancer Market, By Modality 2018 & 2027 (%)
  • 7.3 Diagnosis Type Market
    • 7.3.1 Overview
    • 7.3.2 Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 Immunohistochemistry Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Stool Test Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.5 Flexible Sigmoidoscopy Market
      • 7.3.5.1 Overview
      • 7.3.5.2 Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.6 Colonoscopy Market
      • 7.3.6.1 Overview
      • 7.3.6.2 Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.7 CEA Test Market
      • 7.3.7.1 Overview
      • 7.3.7.2 CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.8 Other Test Market
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Test Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Therapy Type Market
    • 7.4.1 Overview
    • 7.4.2 Global Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Chemotherapy Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.3 Alkylating Agent Market
        • 7.4.3.3.1 Overview
        • 7.4.3.3.2 Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.4 Antimetabolites Market
        • 7.4.3.4.1 Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.5 Others Market
        • 7.4.3.5.1 Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Immunotherapy Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.3 Panitumumab Market
        • 7.4.4.3.1 Overview
        • 7.4.4.3.2 Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.4 Cetuximab Market
        • 7.4.4.4.1 Overview
        • 7.4.4.4.2 Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.5 Bevacizumab Market
        • 7.4.4.5.1 Overview
        • 7.4.4.5.2 Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.6 Others Market
        • 7.4.4.6.1 Overview
        • 7.4.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.5 Chemoprotectant Market
      • 7.4.5.1 Overview
      • 7.4.5.2 Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.6 Others Market
      • 7.4.6.1 Overview
      • 7.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Imaging Type Market
    • 7.5.1 Overview
    • 7.5.2 Global Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.5.3 Computed Tomography (CT) Market
      • 7.5.3.1 Overview
      • 7.5.3.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.4 Magnetic Resonance Imaging (MRI) Market
      • 7.5.4.1 Overview
      • 7.5.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.5 Others Market
      • 7.5.5.1 Overview
      • 7.5.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Global Colorectal Cancer Market Analysis- By End User

  • 8.1 Overview
  • 8.2 Global Colorectal Cancer Market, By End User 2018 & 2027 (%)
  • 8.3 Hospitals Market
    • 8.3.1 Overview
    • 8.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Diagnostic and Research Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 Global Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9. Colorectal Cancer Market Revenue And Forecasts To 2027 - Geographical Analysis

  • 9.1 North America Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.1.1 Overview
    • 9.1.2 North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.3 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.1.3.1 North America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.2 North America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.1 North America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.2 North America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.3 North America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.1.4 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.5 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.6 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.2 US Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.6.2.1 US Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2 US Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.1 US Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.2 US Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.3 US Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.6.3 US Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.7.2.1 Canada Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2 Canada Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.1 Canada Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.2 Canada Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.3 Canada Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.3 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.8 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.1 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.2 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.8.2.1 Mexico Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2 Mexico Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.1 Mexico Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.2 Mexico Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.3 Mexico Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.8.3 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 9.2 Europe Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.2.1 Overview
    • 9.2.2 Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.3 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.2.3.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.3.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.3.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.3.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.3.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.2.4 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.2.5 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.2.6 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.1 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.2 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.2.6.2.1 Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.6.2.2 Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.6.2.2.1 Germany Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.6.2.2.2 Germany Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.6.2.3 Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.6.3 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.2.7 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.1 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.2 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.2.7.2.1 UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.7.2.2 UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.7.2.2.1 UK Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.7.2.2.2 UK Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.7.2.3 UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.7.3 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.2.8 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.1 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.2 France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.2.8.2.1 France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.8.2.2 France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.8.2.2.1 France Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.8.2.2.2 France Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.8.2.3 France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.8.3 France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.2.9 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.1 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.2 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.2.9.2.1 Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.9.2.2 Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.9.2.2.1 Spain Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.9.2.2.2 Spain Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.9.2.3 Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.9.3 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.2.10 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.10.1 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.10.2 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.2.10.2.1 Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.10.2.2 Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.10.2.2.1 Italy Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.10.2.2.2 Italy Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.2.10.2.3 Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.10.3 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 9.3 Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.3 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.3.3.1 Asia Pacific Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.3.2 Asia Pacific Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.3.2.1 Asia Pacific Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.3.2.2 Asia Pacific Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.3.3 Asia Pacific Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.3.4 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.3.5 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.3.6 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.1 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.2 China Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.3.6.2.1 China Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.6.2.2 China Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.6.2.2.1 China Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.6.2.2.2 China Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.6.2.3 China Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.6.3 China Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.3.7 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.1 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.2 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.3.7.2.1 Japan Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.2.2 Japan Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.2.2.1 Japan Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.2.2.2 Japan Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.2.3 Japan Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.7.3 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.3.8 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.1 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.2 India Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.3.8.2.1 India Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.8.2.2 India Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.8.2.2.1 India Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.8.2.2.2 India Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.8.2.3 India Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.8.3 India Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.3.9 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.9.1 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.9.2 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.3.9.2.1 South Korea Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.9.2.2 South Korea Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.9.2.2.1 South Korea Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.9.2.2.2 South Korea Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.9.2.3 South Korea Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.9.3 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.3.10 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.10.1 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.10.2 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.3.10.2.1 Australia Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.10.2.2 Australia Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.10.2.2.1 Australia Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.10.2.2.2 Australia Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.3.10.2.3 Australia Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.10.3 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 9.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.3 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.4.3.1 Middle East & Africa Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.3.2 Middle East & Africa Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.3.2.1 Middle East & Africa Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.3.2.2 Middle East & Africa Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.3.3 Middle East & Africa Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.4.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.4.5 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.4.6 UAE Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.6.1 UAE Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.6.2 UAE Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.4.6.2.1 UAE Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.6.2.2 UAE Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.6.2.2.1 UAE Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.6.2.2.2 UAE Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.6.2.3 UAE Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.6.3 UAE Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.4.7 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.7.1 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.7.2 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.4.7.2.1 Saudi Arabia Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.7.2.2 Saudi Arabia Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.7.2.2.1 Saudi Arabia Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.7.2.2.2 Saudi Arabia Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.7.2.3 Saudi Arabia Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.7.3 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.4.8 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.8.1 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.8.2 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.4.8.2.1 South Africa Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.8.2.2 South Africa Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.8.2.2.1 South Africa Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.8.2.2.2 South Africa Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.4.8.2.3 South Africa Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.8.3 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 9.5 South and Central America Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.5.1 Overview
    • 9.5.2 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5.3 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.5.3.1 South and Central America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.3.2 South and Central America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.3.2.1 South and Central America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.3.2.2 South and Central America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.3.3 South and Central America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.5.4 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.5.5 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.5.6 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.6.1 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.6.2 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.5.6.2.1 Brazil Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.6.2.2 Brazil Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.6.2.2.1 Brazil Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.6.2.2.2 Brazil Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.6.2.3 Brazil Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.6.3 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.5.7 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.7.1 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.7.2 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.5.7.2.1 Argentina Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.7.2.2 Argentina Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.7.2.2.1 Argentina Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.7.2.2.2 Argentina Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.5.7.2.3 Argentina Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.7.3 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10. Colorectal Cancer Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.4 Inorganic Developments
    • 10.4.1 Overview
    • 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019

11. Colorectal Cancer Market-Key Company Profiles

  • 11.1 Epigenomics AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Novigenix SA
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Clinical Genomics Technologies Pty Ltd.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 EDP Biotech Corporation
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Volitionrx Limited
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Abbott Laboratories
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Amgen Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 Pipeline (Clinical Trials) Portfolio
    • 11.7.6 SWOT Analysis
    • 11.7.7 Key Developments
  • 11.8 F. Hoffmann-La Roche AG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 Pipeline (Clinical Trials) Portfolio
    • 11.8.6 SWOT Analysis
    • 11.8.7 Key Developments
  • 11.9 Bruker Corporation
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Quest Diagnostics Incorporated
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Natera, Inc.
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Financial Overview
    • 11.11.4 Product Portfolio
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Guardant Health, Inc.
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Financial Overview
    • 11.12.4 Product Portfolio
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 2. North America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 3. North America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 4. North America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 5. North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 6. North America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 7. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 8. US Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 9. US Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 10. US Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 11. US Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 12. US Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 13. US Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 14. US Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 15. Canada Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 16. Canada Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 17. Canada Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 18. Canada Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 19. Canada Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 20. Canada Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 21. Canada Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 22. Mexico Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 23. Mexico Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 24. Mexico Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 25. Mexico Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 26. Mexico Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 27. Mexico Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 28. Mexico Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 29. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 30. Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 31. Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 32. Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 33. Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 34. Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 35. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 36. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 37. Germany Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 38. Germany Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 39. Germany Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 40. Germany Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 41. Germany Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 42. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 43. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 44. UK Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 45. UK Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 46. UK Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 47. UK Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 48. UK Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 49. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 50. France Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 51. France Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 52. France Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 53. France Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 54. France Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 55. France Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 56. France Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 57. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 58. Spain Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 59. Spain Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 60. Spain Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 61. Spain Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 62. Spain Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 63. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 64. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 65. Italy Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 66. Italy Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 67. Italy Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 68. Italy Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 69. Italy Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 70. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 71. Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 72. Asia Pacific Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 73. Asia Pacific Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 74. Asia Pacific Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 75. Asia Pacific Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 76. Asia Pacific Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 77. Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 78. China Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 79. China Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 80. China Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 81. China Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 82. China Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 83. China Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 84. China Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 85. Japan Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 86. Japan Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 87. Japan Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 88. Japan Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 89. Japan Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 90. Japan Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 91. Japan Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 92. India Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 93. India Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 94. India Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 95. India Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 96. India Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 97. India Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 98. India Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 99. South Korea Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 100. South Korea Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 101. South Korea Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 102. South Korea Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 103. South Korea Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 104. South Korea Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 105. South Korea Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 106. Australia Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 107. Australia Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 108. Australia Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 109. Australia Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 110. Australia Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 111. Australia Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 112. Australia Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 113. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 114. Middle East & Africa Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 115. Middle East & Africa Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 116. Middle East & Africa Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 117. Middle East & Africa Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 118. Middle East & Africa Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 119. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 120. UAE Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 121. UAE Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 122. UAE Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 123. UAE Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 124. UAE Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 125. UAE Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 126. UAE Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 127. Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 128. Saudi Arabia Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 129. Saudi Arabia Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 130. Saudi Arabia Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 131. Saudi Arabia Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 132. Saudi Arabia Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 133. Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 134. South Africa Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 135. South Africa Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 136. South Africa Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 137. South Africa Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 138. South Africa Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 139. South Africa Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 140. South Africa Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 141. South and Central America Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 142. South and Central America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 143. South and Central America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 144. South and Central America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 145. South and Central America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 146. South and Central America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 147. South and Central America Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 148. Brazil Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 149. Brazil Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 150. Brazil Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 151. Brazil Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 152. Brazil Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 153. Brazil Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 154. Brazil Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 155. Argentina Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 156. Argentina Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 157. Argentina Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 158. Argentina Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 159. Argentina Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 160. Argentina Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 161. Argentina Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 162. Recent Organic Growth Strategies In The Colorectal Cancer Market
  • Table 163. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
  • Table 164. Glossary of Terms, Colorectal Cancer Market

LIST OF FIGURES

  • Figure 1. Colorectal Cancer Market Segmentation
  • Figure 2. Colorectal Cancer Segmentation, By Region
  • Figure 3. Global Colorectal Cancer Market Overview
  • Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
  • Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Colorectal Cancer Market, By Geography (US$ Mn)
  • Figure 7. Global Colorectal Cancer Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Colorectal Cancer Market, Industry Landscape
  • Figure 9. Colorectal Cancer Market - North America PEST Analysis
  • Figure 10. Colorectal Cancer Market - Europe PEST Analysis
  • Figure 11. Colorectal Cancer Market - Asia Pacific PEST Analysis
  • Figure 12. Colorectal Cancer Market - Middle East & Africa PEST Analysis
  • Figure 13. Colorectal Cancer Market - South and Central America PEST Analysis
  • Figure 14. Worldwide Colorectal Cancer Epidemiology
  • Figure 15. Comparison of Brand - Name Drugs and Generic Drugs
  • Figure 16. Colorectal Cancer Market Impact Analysis of Drivers And Restraints
  • Figure 17. Global Colorectal Cancer Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 18. Global Colorectal Cancer Market - By Geography Forecasts And Analysis - 2018- 2027
  • Figure 19. Market Positioning Of Key Player In Global Colorectal Cancer Market
  • Figure 20. Global Colorectal Cancer Market, by Modality 2018 & 2027 (%)
  • Figure 21. Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 23. Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 24. Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 25. Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 26. CEA Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 27. Other Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 28. Global Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 30. Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 31. Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 32. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 33. Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 34. Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 35. Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 36. Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 37. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 38. Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 39. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 40. Global Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 42. Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 43. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 44. Global Colorectal Cancer Market, by End User 2018 & 2027 (%)
  • Figure 45. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 46. Global Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. North America Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 48. North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 50. US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 52. Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Europe Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 54. Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 56. Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 58. France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 60. Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 61. Asia Pacific Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 62. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 63. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 64. China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 65. Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 66. India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 67. South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 68. Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 69. Middle East & Africa Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 70. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 71. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 72. UAE Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 73. Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 74. South Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 75. South and Central America Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 76. South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 77. South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 78. Brazil Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 79. Argentina Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 80. Growth Strategies In The Colorectal Cancer Market, 2016-2019